BNB PLUS CORP.
BNBXNasdaq
$0.12
End-of-day
Price
No price history ingested.
Key statistics
Market Cap
$1.2M
Enterprise Value
$214,316.90
P/E
0.0
P/S
0.6
P/B
0.1
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$2.1M
Net Income (TTM)
-$34.5M
Free Cash Flow (TTM)
—
Gross Margin
46.8%
Operating Margin
-1679.1%
Net Margin
-1646.9%
ROE
-275.7%
ROIC
-240.3%
Debt / Equity
—
Net Cash
$949,091.00
Return 1Y
-97.7%
Company profile
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts.
- CEO
- James A. Hayward
- Sector
- Services
- Industry
- Business Services
- Employees
- 70
- Headquarters
- New York
- Website
- adnas.com
Management & directors
- Jantzen BethChief Financial Officer
- Shorrock ClayChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
BNBX Q2 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.0M↑ +34.3%
Diluted EPS-$0.68↓ -99.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $9.0M | $18.2M | $13.4M | $2.1M | $2.1M |
| Gross profit | — | $4.5M | $5.1M | $5.5M | $974,840.00 | $838,907.00 |
| Operating income | -$12.5M | -$13.3M | -$14.0M | -$11.0M | -$13.7M | -$16.0M |
| Net income | -$13.0M | -$14.3M | -$8.3M | -$9.9M | -$7.0M | -$15.2M |
| Diluted EPS | -$3.32 | -$2.07 | -$0.93 | -$15.21 | -$1,366.42 | -$134.23 |
| Operating cash flow | -$11.1M | -$13.4M | -$9.0M | -$6.2M | -$13.7M | — |
| Free cash flow | -$12.2M | -$15.9M | -$9.5M | -$6.3M | -$14.1M | — |
| Gross margin | — | 49.7% | 27.8% | 41.4% | 46.1% | 39.3% |
| Operating margin | -649.0% | -147.9% | -76.9% | -81.9% | -646.7% | -750.9% |
| Net margin | -674.5% | -158.3% | -45.5% | -74.4% | -330.9% | -709.5% |
| Line item | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $472,789.00 | -$180,094.00 | $870,291.00 | $762,822.00 | $304,393.00 | $199,429.00 | $565,394.00 | $1.0M |
| Gross profit | $242,601.00 | $205,491.00 | $606,239.00 | $395,518.00 | $5,130.00 | -$167,980.00 | $315,357.00 | $826,786.00 |
| Operating income | -$3.3M | -$3.0M | -$3.0M | -$3.4M | -$3.7M | -$6.0M | -$18.7M | -$6.8M |
| Net income | $1.9M | -$3.3M | -$2.6M | -$3.3M | -$3.9M | -$5.3M | -$18.6M | -$6.7M |
| Diluted EPS | $1,170.48 | -$2,269.72 | -$417.53 | -$230.30 | -$34.00 | $547.60 | -$2.08 | -$0.68 |
| Operating cash flow | -$3.5M | -$3.2M | -$3.3M | -$3.2M | — | — | — | — |
| Free cash flow | -$3.5M | — | -$3.4M | -$3.4M | — | — | — | — |
| Gross margin | 51.3% | -114.1% | 69.7% | 51.8% | 1.7% | -84.2% | 55.8% | 80.7% |
| Operating margin | -699.3% | 1641.0% | -342.2% | -442.8% | -1213.6% | -3007.1% | -3308.9% | -659.2% |
| Net margin | 397.6% | 1830.6% | -303.3% | -433.2% | -1296.1% | -2643.4% | -3288.6% | -650.8% |
Company news
Jan 28, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-10-17 | Ceccoli Joseph D. | Award | 22,511 | $0.00 | $0.00 | filing |
| 2025-10-17 | CATELL ROBERT B | Award | 22,511 | $0.00 | $0.00 | filing |
| 2025-10-17 | Jantzen Beth· Chief Financial Officer | Award | 18,691 | $0.00 | $0.00 | filing |
| 2025-10-17 | Ferguson Elizabeth M. | Award | 22,511 | $0.00 | $0.00 | filing |
| 2025-10-17 | SHAMASH YACOV A | Award | 22,511 | $0.00 | $0.00 | filing |
| 2025-10-17 | Murrah Judith | Award | 18,691 | $0.00 | $0.00 | filing |
| 2025-10-17 | Shorrock Clay· Chief Executive Officer | Award | 18,691 | $0.00 | $0.00 | filing |
Latest 7 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.